MARKER THERAPEUTICS, INC. (MRKR) Operating cash flow 2016–2025
MARKER THERAPEUTICS, INC. (MRKR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$12.0MFY2025 · since FY2016: -$6.5M → -$12.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.0M | -10.1% |
| FY2024 | -$10.9M | +33.6% |
| FY2023 | -$16.4M | +39.0% |
| FY2022 | -$27.0M | +1.1% |
| FY2021 | -$27.3M | -36.2% |
| FY2020 | -$20.0M | -9.6% |
| FY2019 | -$18.3M | -26.3% |
| FY2018 | -$14.5M | -71.6% |
| FY2017 | -$8.4M | -29.6% |
| FY2016 | -$6.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MRKR financial trends
MRKR RevenueMRKR Net incomeMRKR Net marginMRKR Gross profitMRKR Gross marginMRKR Operating incomeMRKR Operating marginMRKR Free cash flowMRKR Capital expendituresMRKR Return on equityMRKR Stock buybacksMRKR Dividends paidMRKR Total assetsMRKR Total liabilitiesMRKR Shareholders’ equityMRKR overview →